No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Madhukar H. Trivedi M.D. - Brain & Behavior Research Expert on Depression
Madhukar H. Trivedi M.D.
May 12, 2016
Reviving an old treatment for mood problems, researchers find that adding certain opioid medications to depression treatment can help patients who don’t...
May 11, 2016
Rubenstein Associates, Inc.   Public Relations  Contact: Nadine Woloshin 212-843-8041/917-699-9456 nwoloshin@rubenstein.com For Immediate Release NEW YORK...
Carlos A. Zarate, M.D. - Brain & Behavior Research Expert on Depression
Carlos A. Zarate, M.D.
May 06, 2016
Foundation-supported scientists have just solved an important mystery. They have determined how ketamine, a drug approved long ago as an anesthetic but used...
Amanda J. Law, Ph.D. - Brain & Behavior Research Expert on Schizophrenia
Amanda J. Law, Ph.D.
May 05, 2016
Researchers have developed a new model for studying schizophrenia by genetically engineering mice that produce high levels of a human protein, NRG1-IV, in the...
Jeffrey R. Bishop, Pharm.D., M.S. - Brain & Behavior Research Expert on Schizophrenia
Dr. Jeffrey R. Bishop
May 02, 2016
People's genes may determine how they respond to medications for psychosis. In a new study published February 23, 2016 in Translational Psychiatry, researchers...

Pages

Subscribe to